Clinical Trial Detail

NCT ID NCT01351909
Title Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors National Cancer Institute (NCI)
Indications

Her2-receptor negative breast cancer

Therapies

Cyclophosphamide

Veliparib

Age Groups: adult senior

Additional content available in CKB BOOST